These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15039470)

  • 1. Tumor lysis syndrome following a single dose of capecitabine.
    Kurt M; Eren OO; Engin H; Güler N
    Ann Pharmacother; 2004 May; 38(5):902. PubMed ID: 15039470
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of capecitabine-induced hyperpigmentation and radiation recall phenomenon.
    Ghosal N; Misra V
    Clin Oncol (R Coll Radiol); 2009 Oct; 21(8):632. PubMed ID: 19304468
    [No Abstract]   [Full Text] [Related]  

  • 3. Granulomatous septal panniculitis associated with capecitabine (Xeloda).
    Dalmau J; Roé E; Puig L; Alomar A
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):121-2. PubMed ID: 18181993
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor lysis syndrome after capecitabine plus cisplatin treatment in advanced gastric cancer.
    Han HS; Park SR; Kim SY; Park YI; Lee JS; Kook MC; Choi IJ; Kim CG; Lee JR; Cho SJ; Kim NK
    J Clin Oncol; 2008 Feb; 26(6):1006-8. PubMed ID: 18281674
    [No Abstract]   [Full Text] [Related]  

  • 5. [A woman with palmar and plantar hyperpigmentation].
    van Tienhoven G; Wilmink JW
    Ned Tijdschr Geneeskd; 2011; 155(45):A4100. PubMed ID: 22085578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nursing considerations for capecitabine-based combination therapy.
    Becze E
    ONS Connect; 2009 Apr; 24(4):14-5. PubMed ID: 19413236
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tumor specific therapy. Targeted breast cancer therapy].
    MMW Fortschr Med; 2003 Sep; 145(38):62. PubMed ID: 14603691
    [No Abstract]   [Full Text] [Related]  

  • 8. Actinic keratosis and capecitabine therapy.
    Higa GM; Kovach RF; Abraham J
    J Oncol Pharm Pract; 2005 Dec; 11(4):151-3. PubMed ID: 16595067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lethal toxicity of capecitabine due to abusive folic acid prescription?
    Clippe C; Freyer G; Milano G; Trillet-Lenoir V
    Clin Oncol (R Coll Radiol); 2003 Aug; 15(5):299-300. PubMed ID: 12924465
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of capecitabine in cancer: management of the hand foot syndrome.
    Sudoyo AW
    Acta Med Indones; 2005; 37(3):174-6. PubMed ID: 16110178
    [No Abstract]   [Full Text] [Related]  

  • 11. [Severe capecitabine-associated toxicity in a patient carrying a mutation in the dihydropyrimidine dehydrogenase gen].
    González-Haba E
    Farm Hosp; 2012; 36(6):554-5. PubMed ID: 23461455
    [No Abstract]   [Full Text] [Related]  

  • 12. Coronary spasm induced by capecitabine.
    Schnetzler B; Popova N; Collao Lamb C; Sappino AP
    Ann Oncol; 2001 May; 12(5):723-4. PubMed ID: 11432636
    [No Abstract]   [Full Text] [Related]  

  • 13. Capecitabine and PPE syndrome: a case report.
    LoRusso PM
    Breast J; 2003; 9(1):64-5. PubMed ID: 12558679
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe hypertriglyceridaemia associated with the use of capecitabine.
    Polinder-Bos HA; Kok EE; van de Wiel A; Spiering W; Wielders JP; Bloemendal HJ
    Neth J Med; 2012 Mar; 70(2):104. PubMed ID: 22418760
    [No Abstract]   [Full Text] [Related]  

  • 15. Uncontrolled hypertriglyceridemia induced by capecitabine: case report and review of the literature.
    Bar-Sela G; Haim N
    Cancer Chemother Pharmacol; 2009 Apr; 63(5):779-82. PubMed ID: 18641989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucositis as a treatment-limiting side effect in the use of capecitabine for the treatment of metastatic breast cancer.
    Bell KA; Perna AG; Hsu S
    J Am Acad Dermatol; 2001 Nov; 45(5):790-1. PubMed ID: 11606938
    [No Abstract]   [Full Text] [Related]  

  • 17. Single-agent capecitabine maintenance therapy after response to capecitabine-based combination chemotherapy in patients with metastatic breast cancer.
    Huang H; Jiang Z; Wang T; Zhang S; Bian L; Cao Y; Wu S; Song S
    Anticancer Drugs; 2012 Aug; 23(7):718-23. PubMed ID: 22739713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unprecedented case of tumor lysis syndrome in a patient with metastatic pancreatic adenocarcinoma.
    Ling W; Sachdeva P; Wong AS; Lee SC; Zee YK
    Pancreas; 2012 May; 41(4):659-61. PubMed ID: 22504387
    [No Abstract]   [Full Text] [Related]  

  • 19. [Capecitabine-induced hyperpigmentation followed by hand-foot syndrome: a new case report].
    Agharbi FZ; Meziane M; Benhemmne H; Daoudi K; Elmesbahi O; Mikou O; Mernissi FZ
    Ann Dermatol Venereol; 2012 Mar; 139(3):221-2. PubMed ID: 22401689
    [No Abstract]   [Full Text] [Related]  

  • 20. Subacute cutaneous lupus erythematosus associated with capecitabine monotherapy.
    Fernandes NF; Rosenbach M; Elenitsas R; Kist JM
    Arch Dermatol; 2009 Mar; 145(3):340-1. PubMed ID: 19289781
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.